A researcher has retracted a paper from Diabetes after re-using some Western blots in one of the figures from other papers.
According to the retraction notice, the first and corresponding author — Eric Berglund, formerly at Vanderbilt University in Nashville, Tennessee — contacted the journal himself to report the error, for which he takes full responsibility.
Here’s the retraction notice: Continue reading Author pulls Diabetes paper with duplicated Western blots
A journal has retracted a 2015 study about lung cancer after learning the peer-review process had been compromised.
The paper was published in March, 2015 — the same month publisher BioMed Central (BMC) pulled 43 papers for fake reviews.
According to the retraction notice in the European Journal of Medical Research, the authors’ institution in China informed the publisher that the authors had used a third party to help with copyediting and submission to the journal, raising concerns about the authorship of the paper.
Here’s the retraction notice, published in August: Continue reading Medical journal retracts study over fake review, authorship concerns
A neuroscience journal has retracted a 2015 study after noticing the author list changed from submission to publication.
According to the retraction notice in the International Journal of Neuroscience, “conflicting messages” were conveyed between the study’s alleged two lead authors, causing the journal to doubt the provenance of the paper.
All the study’s authors are listed as affiliated with The People’s Hospital of Laiwu City in Shandong, China.
Here’s the retraction notice, issued earlier this year: Continue reading Neuro journal pulls paper due to doubts over authors’ identities
In a massive cleanup, Springer and BioMed Central announced today they are retracting 58 papers for several reasons, including manipulation of the peer-review process and inappropriately allocating authorship.
The papers appeared in seven journals, and more are under investigation.
In a release issued today, the publishers note: Continue reading Springer, BMC retracting nearly 60 papers for fake reviews and other issues
A researcher is claiming that her former PhD students impersonated her to remove her name as a co-author on a 2015 study.
According to an editor’s note, published in Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, the journal received confirmation from all three authors that the aforementioned researcher should be removed from the author list during proofing stage. However, the researcher whose name was omitted — Nahid Nishat of the Jamia Millia Islamia in Jamia Nagar, New Delhi, India — later contacted the journal claiming that she didn’t okay this move.
Nishat told Retraction Watch that she believes the two listed authors on the paper wrote to the journal on her behalf to remove her name: Continue reading Who wrote this chem paper? Author claims her name was removed without consent
Researchers have retracted a study about malaria infections in India after follow-up research unveiled problems with the data and set off a dispute among the authors.
According to the notice, when the authors continued their research on the same topic, some of the new data raised concerns about what was reported in the 2010 paper. That set off a “number of disputes between authors,” which led them to retract the paper.
This account was supported by the study’s first and corresponding author, Naitik Trivedi, from the A.R. College of Pharmacy & G.H. Patel Institute of Pharmacy in Anand, Gujarat, India. Trivedi told us he believes the previous study didn’t include some relevant parameters, which affected the results.
Trivedi noted that all the authors agree to the retraction, adding: Continue reading Authors pull malaria study after arguing over the results
A materials journal has retracted two 2013 papers, citing an investigation at Pennsylvania State University that concluded the first author falsified data.
According to the retraction notice in Advanced Materials, Mehdi Ghaffari — formerly based at Penn State — was solely responsible for the misconduct. Ghaffari’s LinkedIn page says he finished his PhD at Penn State in 2014, and now works as an independent consultant in New York, after a stint as a postdoc at Procter and Gamble.
A Penn State spokesperson sent us this statement: Continue reading Materials researcher falsified data in two studies, probe reveals
Journals have flagged two papers by prominent social psychologist Jens Förster — whose work has been subject to much scrutiny — over concerns regarding the validity of the data.
Förster already has three retractions, following an investigation by his former employer, the University of Amsterdam (UvA) in the Netherlands. In 2014, we reported on the first retraction for Förster for one of three studies with odd patterns that were flagged by the UvA investigation, a 2012 paper in Social Psychological and Personality Science; subsequently, the Netherlands Board on Research Integrity concluded that data had been manipulated. Three statistical experts from the UvA then carried out a more in-depth analysis of 24 publications by Förster, and found eight to have “strong evidence for low scientific veracity.”
Last year, Förster agreed to retract two more papers as part of a deal with the German Society for Psychology (DGPs); those retractions appeared earlier this year. All three papers that Förster has lost until now are from the “strong evidence for low scientific veracity” category. Recently, two more of Förster’s papers from the same category were flagged with notices, but not retracted.
One “statement of institutional concern,” issued by Personality and Social Psychology Bulletin, reads:
Continue reading Journals flag two papers by psychologist Jens Förster
A retracted study linking the vaccine for human papillomavirus (HPV) to behavioral problems in mice has been republished by a different journal.
The paper has been significantly revised, an author told us, but it still comes the same conclusions.
In February, the journal Vaccine temporarily removed the study without explanation, and told the authors the editor had asked for further review. Later that month, Vaccine retracted the paper, citing “serious concerns regarding the scientific soundness of the article,” and “seriously flawed” methodology.
In July, another journal — Immunologic Research — republished the paper. The new version of the paper has been significantly changed, co-author Christopher Shaw from the University of British Columbia (UBC) told Retraction Watch:
Did you know there is a black market for scientific papers? Unfortunately, there is a growing trend of authors purchasing a spot on the author list of papers-for-sale – and the better the journal, the higher the price. This worrisome trend has been on the minds of Peggy Mason at the University of Chicago and Maria Sol Bernardez Sarria of Yale University, formerly associated with the Ethics Committee of the Society for Neuroscience, which publishes the Journal of Neuroscience (Mason as Chair from 2013 to 2015, and Bernardez Sarria as assistant). In this capacity, they regularly scanned several websites and journals for ethics-related information, and developed an approach that might give away sold authorship. Continue reading 7 signs a scientific paper’s authorship was bought